Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  18F-fluoromisonidazole
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-16 of 16 for your search:
Start Over
MR-PET Guided Biologically Optimised Interstitial Brachytherapy
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: TMH-IRB 843, NCT01391065
Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO
Phase: Phase II
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: HNO-FMISO-FU, NCT00180180
Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-00107, CDR0000721619, RTOG-1106/ACRIN-6697, RTOG-1106, U10CA180868, U10CA021661, NCT01507428
FMISO-PET in Brain Tumors and SCS Effect
Phase: Phase II
Type: Diagnostic, Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: TC-FMISO-PET-06-1413, 2009-015852-11, PI 06/1413, PI 12/02940, NCT01868906
Evaluation of Hypoxia by PET With F-Miso in Radiation Therapy of Prostate Cancer
Phase: Phase II
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: RC11-080, 2011-004582-32, NCT01898065
Biomarker Correlates of Hypoxia in Metastatic Melanoma
Phase: Phase II
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MCC-17034, NCT02061007
FMISO PET Study of Glioblastoma
Phase: Phase II
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 13-482, R01CA129371, NCT02076152
Palliative Thoracic Radiotherapy Plus BKM120
Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: OCTO_031, 2012-003762-40, NCT02128724
Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 04-070, NCT00606294
Imaging and Biomarkers of Hypoxia in Solid Tumors
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: VAR0032, NCT01123005
Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: HCI44704, NCT01246869
Predictive Value of FMISO-PET, FDG-PET-CT, DWI-MRI and DCE-MRI Scans for Patients With Anal Cancer Receiving Radiotherapy +/- Chemotherapy
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: GI 1026, NCT01330186
Relationship Between Hypoxia and Endocrine Response in Human Breast Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Active
Age: 60 to 90
Sponsor: Other
Protocol IDs: 20120224.1.1, NCT01814449
Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 13-186, U01CA157442-01A1, NCT02016872
RHYTHM-I: Investigating Hypoxia in Rectal Tumours
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: OCTO_043, NCT02157246
Start Over